1
Have a requirement?
Chat with us
1
Have a requirement?
Chat with us
Our Product Range
18 products available
- 40mg Adalirel Adalimumab Injection
- 40mg Azimbra, Adalimumab Injection
- 1% W/V Halonix One Sodium Hyaluronic Injection
- 2mg Olumiant Baricitinib Tablet
- 4mg Olumiant Baricitinib Tablet
- 50mg Intacept Etanercept Injection
- 60mg Durolane Injection, Hyaluronic Acid Injection
- 100mg Infimab Infliximab Injection
- 5 Mg Intajac Tofacitinib Tablets
- 5mg Jakura Tofacitinib Tablets
- 600mg Terifrac Solo Injection
- 750mcg Terifrac Teriparatide Injection
- 6mg Bandrone Ibandronic Acid Injection
- 150mg Bandrone Ibandronate Tablets
- 150mg Idrofos Ibandronic Acid Tablets
- 50mg Bandrone Ibandronic Acid Tablets
- 600mcg Gemtide Teriparatide Injection
- Exemptia 40 Mg Adalimumab Injection
Arthritis Medicines
Wholesale Distributor of a wide range of products which include 40mg Adalirel Adalimumab Injection, 40mg Azimbra, Adalimumab Injection, 1% W/V Halonix One Sodium Hyaluronic Injection, 2mg Olumiant Baricitinib Tablet, 4mg Olumiant Baricitinib Tablet and 50mg Intacept Etanercept Injection.
₹ 6,200/Box
₹ 5,500/Box
₹ 4,500/Box
₹ 7,000/Box
₹ 7,000/Box
₹ 4,200/Box
₹ 10,000/Box
₹ 11,500/Box
₹ 200/Box
₹ 400/Box
₹ 4,300/Piece
₹ 2,900/Piece
₹ 1,070/Strip
₹ 450/Piece
₹ 790/Piece
₹ 400/Piece
₹ 3,500/Piece
₹ 3,000/Box
Interested in this product?
Get Best Quote
40mg Adalirel Adalimumab Injection
₹ 6,200/BoxGet Latest Price
Minimum Order Quantity: 1 Box
Product Brochure Watch Video
| Brand Name | Adalirel |
| Strength / Dose | 40mg |
| Packaging Type | Vial |
| Manufacturer | Reliance Lifescience |
| Brand | Adalirel |
| Strength | 40mg/0.8mL |
| Packaging Size | 0.8ml |
| Usage | Rheumatoid arthritis |
Adalirel (adalimumab) blocks TNF-alpha, a protein central to the inflammatory response in RA and several other immune conditions. It provides effective symptom control, reduces risk of joint and tissue damage, and maintains remission when used as long-term therapy. It is administered as SC injection every two weeks and can be stored at 2-8°C. Side effects include upper respiratory infections, injection site reactions, rash, and in rare cases, TB reactivation or lymphoma. Safety data are established for chronic administration, and regular physician visits/screens are recommended.
Brands available:
-
Exemptia 40mg Injection (ZYDUS CADILA)
-
Mabvinra 40mg Injection (ALKEM LABORATORIES)
-
Plamumab 40mg Injection (CIPLA LTD)
-
Adlumab 40mg Injection (RPG LIFE SCIENCES)
-
Azimbra 40mg Injection (ABBOTT)
-
Adalipca 40mg Injection (IPCA LABORATORIES)
-
Adfrar 40mg Injection (TORRENT PHARMACEUTICALS)
-
Amab 40mg Injection (DR REDDY'S LABORATORIES)
-
Humimab HC 40mg Injection (SUN PHARMACEUTICALS)
-
Adalirel 40mg Injection (RELIANCE LIFE SCIENCES)
-
Bonmiraa 40mg Injection (PHOENIX BIOMED)
-
Mabura 40mg Injection (HETERO HEALTHCARE LTD)
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Brand Name | Azimbra |
| Strength / Dose | 40mg |
| Packaging Type | Vial |
| Manufacturer | Abbott |
| Brand | Azimbra |
| Strength | 40mg/0.4mL |
| Packaging Size | 0.4ml |
| Usage | Rheumatoid arthritis |
Azimbra contains adalimumab, a fully human monoclonal antibody that blocks tumor necrosis factor alpha (TNF-??), a key cytokine involved in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Azimbra is administered subcutaneously and effectively reduces joint inflammation, pain, and damage. Side effects include increased susceptibility to infections (including tuberculosis), injection site reactions, and possible infusion-related reactions. Patients require screening for latent tuberculosis and close monitoring during treatment. Use in pregnancy or breastfeeding should be under strict medical advice. Prior vaccination and infection history must be reviewed.
Brands available:
-
Exemptia 40mg Injection (ZYDUS CADILA)
-
Mabvinra 40mg Injection (ALKEM LABORATORIES)
-
Plamumab 40mg Injection (CIPLA LTD)
-
Adlumab 40mg Injection (RPG LIFE SCIENCES)
-
Azimbra 40mg Injection (ABBOTT)
-
Adalipca 40mg Injection (IPCA LABORATORIES)
-
Adfrar 40mg Injection (TORRENT PHARMACEUTICALS)
-
Amab 40mg Injection (DR REDDY'S LABORATORIES)
-
Humimab HC 40mg Injection (SUN PHARMACEUTICALS)
-
Adalirel 40mg Injection (RELIANCE LIFE SCIENCES)
-
Bonmiraa 40mg Injection (PHOENIX BIOMED)
-
Mabura 40mg Injection (HETERO HEALTHCARE LTD)
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
1% W/V Halonix One Sodium Hyaluronic Injection
₹ 4,500/BoxGet Latest Price
Product Brochure Watch Video
| Packaging Type | Vial |
| Manufacturer | Cadila Pharmaceuticals |
| Packaging Size | 6ml |
| Brand | Halonix |
| Usage/Application | Osteoarthritis |
| Strength | 1% w/v |
| Composition | Sodium Hyaluronic |
| Hyaluronic Acid acts as a viscosupplement, restoring synovial fluid viscosity in osteoarthritic joints, facilitating shock absorption and lubrication, thereby reducing friction. Used mainly in knee OA with minimal side effects. Well tolerated except mild injection site pain or swelling. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength / Dose | 2 mg |
| Packaging Type | Strip |
| Packaging Size | 7 Tablets |
| Brand | Olumiant |
| Manufacturer | Lilly |
| Usage | For Covid Treatment |
| Olumiant (baricitinib) is a selective Janus kinase (JAK) inhibitor used primarily for moderate to severe rheumatoid arthritis in adults nonresponsive to DMARDs and for Covid-19 in combination with other medications. Baricitinib blocks JAK1/JAK2 to suppress cytokine signaling, thus decreasing inflammation, pain, swelling, and joint destruction in RA. It is given as once-daily tablets, absorbed orally, with improvement seen soon after therapy initiation and peaking in a few months. The medication is also repurposed to treat hospitalized COVID-19 patients to decrease the progression to ventilation or death. Adverse reactions: upper respiratory tract infection, nausea, cold sores, viral infection, and increased risk of thrombosis. Prior to initiation, screen for tuberculosis and hepatitis B/C. Blood counts, liver enzymes, and lipids should be monitored. Not recommended for use in pregnancy, lactation, or in children. Adherence and scheduled monitoring are crucial for safe long-term outcomes. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength / Dose | 4 mg |
| Packaging Type | Strip |
| Packaging Size | 7 Tablets |
| Brand | Olumiant |
| Manufacturer | Lilly |
| Usage | For Covid Treatment |
| Olumiant contains baricitinib, a targeted Janus kinase (JAK) inhibitor that blocks JAK1 and JAK2 enzymes, interrupting the inflammatory pathway involved in rheumatoid arthritis. By selectively targeting JAK-mediated signaling, Olumiant helps in reducing joint pain, stiffness, and swelling, and slows down the progression of bone and cartilage damage. This therapy is indicated in adults with moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to one or more DMARDs. The standard dose is usually 4mg once daily, but may be adjusted based on disease response and safety. Key side effects include upper respiratory tract infections, headache, increased risk of herpes zoster, and blood clot formation. Patients should undergo regular blood tests for cell counts, liver enzymes, and lipid monitoring. Olumiant has a rapid onset of action with some patients experiencing relief in symptoms within the first week of therapy, with maximum benefits seen after several months of continuous use. It is contraindicated in pregnancy and should be used with caution in immunocompromised patients. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 50mg |
| Packaging Size | 1ml |
| Brand | Intacept |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packaging Type | Vial |
| Usage/Application | Ankylosing Spondylitis |
| Composition | Etanercept |
| Intacept is etanercept, a fusion protein that acts as a TNF-alpha inhibitor, binding TNF and blocking its interaction with cell surface receptors. It is indicated for moderate to severe rheumatoid and psoriatic arthritis, ankylosing spondylitis, and chronic plaque psoriasis. The drug is given as a weekly (or more often initially) subcutaneous injection. Clinical trials demonstrate improved mobility, reduction in pain, less swelling, and slowed disease progression. Side effects are generally mild: injection site reactions, headache, and mild infections are most common. Serious risks include TB or serious infections, demyelinating disease, and rare blood disorders. All patients should be screened for latent TB before starting therapy. Therapy is not recommended in pregnancy, for those with active infection, or in CHF. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
60mg Durolane Injection, Hyaluronic Acid Injection
₹ 10,000/BoxGet Latest Price
Product Brochure Watch Video
| Packaging Type | Vial |
| Packaging Size | 2ml |
| Brand | Durolane |
| Shelf Life | 36 Months |
| Usage/Application | Osteoarthritis |
| Strength | 60mg |
| Durolane’s hyaluronic acid is stabilized using NASHA (Non-Animal Stabilized Hyaluronic Acid) technology, designed for superior durability and prolonged effect following a single injection into the affected joint (commonly knee or hip). By restoring viscosity and elasticity to synovial fluid, it cushions joints and promotes natural movement. Most patients report pain relief for up to six months post-injection. Clinical studies confirm safety and efficacy; the most common adverse events include temporary pain and swelling at the injection site. Durolane is not recommended for patients with joint infections, or allergy to HA products. Administered under sterile conditions by a healthcare professional. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Packaging Type | Vial |
| Strength | 100 mg |
| Brand | Infimab |
| Manufacturer | Reliance Lifescience |
| Usage/Application | Rheumatoid Arthritis |
| Pack Size | 1ml |
| Composition | Infliximab |
| Infimab contains Infliximab, a monoclonal antibody TNF inhibitor for diseases like RA, AS, psoriasis, ulcerative colitis/Crohn’s. Administered as IV infusion. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Manufacturer | Intas |
| Packaging Type | Box |
| Strength | 5 mg |
| Brand | Intajac |
| Packaging Size | 60 Tablets |
| Composition | Tofacitinib 5mg |
| Usage | Rheumatoid arthritis |
| 5mg strength suitable for twice-daily dosing, used to reduce inflammation, pain, and radiographic progression. Follow-up monitoring is advised per guidelines. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Manufacturer | Hetero Healthcare |
| Packaging Type | Box |
| Strength | 5 mg |
| Brand | Jakura |
| Packaging Size | 60 Tablets |
| Composition | Tofacitinib 5mg |
| Usage | Rheumatoid arthritis |
| Jakura 5mg’s tofacitinib is prescribed for persistent RA not controlled by DMARDs. Mechanism: JAK inhibition reduces interleukin and cytokine-mediated inflammatory damage, bringing rapid symptom relief and improved quality of life. Regular lab and clinical monitoring advised to prevent complications of immunosuppression. Side effects parallel labeled warnings for the class. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 600 mcg |
| Pack Size | 2.4ml |
| Pack Type | Cartridge |
| Brand | Terifrac |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usage/Application | To Treat Osteoporosis |
| Terifrac Solo, with teriparatide, is appropriate for osteoporosis secondary to menopause or steroid therapy in patients with multiple fractures. Effective at fracture prevention and BMD improvement when used with lifestyle/dietary optimization. Max recommended: 2 years. Most side effects are mild, including cramps and transient nausea. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 750 mcg |
| Pack Size | 3ml |
| Pack Type | Cartridge |
| Brand | Terifrac |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usage/Application | To Treat Osteoporosis |
Terifrac contains teriparatide, a bioengineered form of parathyroid hormone. Indicated for osteoporosis in men and postmenopausal women with high fracture risk or after major osteoporotic fracture. It promotes bone anabolism by stimulating osteoblastic activity. Administered daily SQ, max duration 2 years. Typical adverse reactions include leg cramps, nausea, transient hypercalcemia, and local site reactions. Terifrac is contraindicated in persons with hyperparathyroidism, history of bone malignancy, or prior irradiation to the skeleton. Periodic monitoring of serum calcium, kidneys, and 25-OH vitamin D levels is standard care. Diet/exercise support therapy for best results.
Brands available:
-
Bonmax PTH 750mcg Cartridge 1's (ZYDUS CADILA)
-
Nu Pth 750mcg Injection (CADILA PHARMACEUTICALS)
-
Zotide 750mcg Injection (CIPLA LTD)
-
Rockbon PTH Pen Injection (ABBOTT)
-
Bonspark Cartridge 750mcg Injection (GLENMARK PHARMACEUTICALS)
-
Teripro PTH 750mcg Injection (BRIN TON PHARMA)
-
Bonmax PTH 750mcg Cartridge 3's (ZYDUS CADILA)
-
Osteri 750mcg Injection (EMCURE PHARMACEUTICALS)
-
Gemtide 750mcg Injection (ALKEM LABORATORIES)
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 6 mg |
| Pack Size | 1 ml |
| Pack Type | Vial |
| Drug Composition | Ibandronic Acid 6mg |
| Brand | Bandrone |
| Manufacturer | Natco |
| Usage/Application | To Treat Osteoporosis |
| Bandrone 6mg Injection is an intravenous bisphosphonate that inhibits osteoclast-mediated bone resorption, increasing bone mineral density and reducing vertebral fracture risk in postmenopausal osteoporosis. The infusion is administered by healthcare professionals, typically once every 3 months or as prescribed. It is often used for patients unable to tolerate oral bisphosphonates. Side effects may include flu-like symptoms post-infusion, hypocalcemia, and injection site irritation. It is essential to ensure adequate calcium and vitamin D levels before starting therapy. Monitoring of renal function is advised, and it is contraindicated in patients with severe renal impairment. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 150 mg |
| Pack Size | 1 Tablets |
| Pack Type | Box |
| Drug Composition | Ibandronic Acid 150mg |
| Brand | Bandrone |
| Manufacturer | Natco |
| Usage/Application | To Treat Osteoporosis |
| Bandrone 150mg is a bisphosphonate that prevents bone resorption by inhibiting osteoclast activity, strengthening bones and lowering fracture risk in postmenopausal women with osteoporosis. Recommended to take on an empty stomach with water, with regular calcium and vitamin D intake, and lifestyle modifications like exercise. Side effects include headache, musculoskeletal pain, heartburn, diarrhea, dizziness; serious risks include jaw osteonecrosis and low blood calcium needing prompt attention. Contraindicated in patients with esophageal abnormalities or inability to sit upright. Requires regular monitoring of bone health and kidney function during treatment. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 150 mg |
| Pack Size | 1*3 Tablets |
| Pack Type | Box |
| Drug Composition | Ibandronic Acid 150mg |
| Brand | Idrofos |
| Usage/Application | To Treat Osteoporosis |
| Idrofos 150mg, a bisphosphonate, acts by inhibiting osteoclastic bone resorption for osteoporosis management in postmenopausal women. Taken on an empty stomach with water; benefits maximize with calcium and vitamin D supplementation and weight-bearing exercise. Side effects similar to bisphosphonates include gastrointestinal issues, headache, musculoskeletal pain, and rare but serious adverse events like osteonecrosis of the jaw and hypocalcemia. Liver and renal functions must be monitored during prolonged treatment. Not recommended for pregnant patients or those with esophageal disorders. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Pack Size | 3x10 Tablets |
| Pack Type | Box |
| Drug Composition | Ibandronic Acid 150mg |
| Brand | Bandrone |
| Manufacturer | Natco |
| Usage/Application | To Treat Osteoporosis |
| Strength | 150 mg |
| Bandrone 50mg tablets are oral bisphosphonates to inhibit osteoclast-mediated bone resorption, maintain bone density, and reduce fracture risk in osteoporosis. Administration is recommended on an empty stomach with water, with calcium/vitamin D supplementation and lifestyle changes advised. Side effects may include GI discomfort, headache, musculoskeletal pain, heartburn, and constipation. Caution in renal impairment. Regular bone density monitoring and dental evaluation are advised to mitigate risks like osteonecrosis of the jaw. Not suitable during pregnancy or lactation. |
View Complete Details
Yes, I am interested!
Interested in this product?
Get Best Quote
| Strength | 600 mcg |
| Packaging Type | Pre-Filled Pen |
| Packaging Size | 2.4ml |
| Composition | Teriparatide 600mcg |
| Brand | Gemtide |
| Manufacturer | Alkem |
| Usage/Application | To Treat Osteoporosis |
Teriparatide in Gemtide is used for men and postmenopausal women with osteoporosis, especially those with history of major fractures. Mechanism: stimulates osteoblasts, reverses bone loss, and increases bone mineral density significantly. Requires daily injection and follow-up for calcium levels and kidney function. Store in refrigerator. Continue exercise and calcium/vitamin D supplementation.
Brands available:
-
Gemfrac 600mcg Injection (ALKEM LABORATORIES)
-
TPT 20 600mcg Injection (RPG LIFE SCIENCES)
-
Osteri 600mcg Injection (EMCURE PHARMACEUTICALS)
-
Terifrac Solo 600mcg Injection (INTAS PHARMACEUTICALS)
-
Zotide ONE 600mcg Injection 2.4ml (CIPLA LTD)
-
Bonista PF Injection (SUN PHARMACEUTICALS)
-
Forteo 600mcg Injection (ELI LILLY AND COMPANY)
View Complete Details
Yes, I am interested!
| Brand Name | Exemptia |
| Presentation | PFS |
| Manufacturer | Zydus |
| Strength | 40mg/0.8mL |
| Pack Size | 1 Injection |
| Usage | Single-Use |
Adalimumab, a fully human monoclonal antibody that blocks tumor necrosis factor alpha (TNF-??), a key cytokine involved in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Azimbra is administered subcutaneously and effectively reduces joint inflammation, pain, and damage. Side effects include increased susceptibility to infections (including tuberculosis), injection site reactions, and possible infusion-related reactions. Patients require screening for latent tuberculosis and close monitoring during treatment. Use in pregnancy or breastfeeding should be under strict medical advice. Prior vaccination and infection history must be reviewed.
Brands available:
-
Exemptia 40mg Injection (ZYDUS CADILA)
-
Mabvinra 40mg Injection (ALKEM LABORATORIES)
-
Plamumab 40mg Injection (CIPLA LTD)
-
Adlumab 40mg Injection (RPG LIFE SCIENCES)
-
Azimbra 40mg Injection (ABBOTT)
-
Adalipca 40mg Injection (IPCA LABORATORIES)
-
Adfrar 40mg Injection (TORRENT PHARMACEUTICALS)
-
Amab 40mg Injection (DR REDDY'S LABORATORIES)
-
Humimab HC 40mg Injection (SUN PHARMACEUTICALS)
-
Adalirel 40mg Injection (RELIANCE LIFE SCIENCES)
-
Bonmiraa 40mg Injection (PHOENIX BIOMED)
-
Mabura 40mg Injection (HETERO HEALTHCARE LTD)
View Complete Details
Yes, I am interested!
Tell us what you need, and we’ll help you get quotes
Tell us what you
need
need
Receive seller
details
details
Seal the deal
Pay with IndiaMART